Dr Eva Perez

Postdoctoral Scientist

Immunology, Vaccinology, Virology

Eva studied for her DVM at the University of Barcelona, Spain. After completing her PhD in Medicine and Animal Health at the Centre of Research in Animal Health (CReSA), Barcelona, she took up a post-doctoral position at Plum Island Animal Disease Center (PIADC), USA. During this time, Eva worked on the innate immune response and the use of biotherapeutics for controlling foot-and-mouth disease (FMD). Eva then moved to a second postdoc at The Pirbright Institute, in the UK, where she is currently investigating the development of new vaccines against FMD and the persistence of FMD virus in mice models and in its natural host, the African buffalo.

News
Publications

Pirbright grants licence for new foot-and-mouth disease vaccine

Persistently infected African buffalo not a likely cause of new FMD outbreaks say Pirbright scientists

Pirbright switches it up: creating foot-and-mouth disease hybrids for better vaccines

Pirbright study to improve the production and supply of foot-and-mouth disease vaccine

Designing foot-and-mouth disease synthetic vaccine design using computer simulations

Cortey M, Ferretti L, Perez-Martin E, Zhang F, de Klerk-Lorist L M, Scott K, Freimanis G, Seago J, Ribeca P, van Schalkwyk L, Juleff N D, Maree F F, Charleston B (2019)

Persistent infection of African buffalo (Syncerus caffer) with foot-and-mouth disease virus: limited viral evolution and no evidence of antibody neutralization escape

Journal of Virology 93 (15) , e00563-19

Publisher’s version: https://doi.org/10.1128/JVI.00563-19

Ferretti L, Di Nardo A, Singer B, Lasecka-Dykes L, Logan G, Wright C F, Pe?rez-Marti?n E, King D P, Tuthill T J, Ribeca P (2018)

Within-host recombination in the foot-and-mouth disease virus genome

Viruses 10 (5) , 221

Publisher’s version: https://dx.doi.org/10.3390/v10050221

Glidden C K, Beechler B, Buss P E, Charleston B, de Klerk-Lorist L-M, Maree F F, Muller T, Pérez-Martin E, Scott K A, van Schalkwyk O L, Jolles A (2018)

Detection of pathogen exposure in African buffalo using non-specific markers of inflammation

Frontiers in Immunology 8 , 1944

Publisher’s version: https://doi.org/10.3389/fimmu.2017.01944

Kotecha A, Perez-Martin E, Harvey Y, Zhang F, Ilca S L, Fry E E, Jackson B, Maree F, Scott K, Hecksel C W, Harmsen M M, Mioulet V, Wood B, Juleff N, Stuart D I, Charleston B, Seago J (2018)

Chimeric O1K foot-and-mouth disease virus with SAT2 outer capsid as an FMD vaccine candidate

Scientfic Reports 8 , 13654

Publisher’s version: https://doi.org/10.1038/s41598-018-31856-x

Loureiro S, Porta C, Maity H, Perez E, Bagno F, Kotecha A, Fry E, Ren J, Stuart D, Hoenemann H, Serrano A, van den Born E, Charleston B, Jones I (2018)

Universal detection of foot and mouth disease virus based on the conserved VP0 protein

Wellcome Open Research 3 , 88

Publisher’s version: https://dx.doi.org/10.12688/wellcomeopenres.14655.1

Harmsen M M, Seago J, Perez E, Charleston B, Eblé P L, Dekker A (2017)

Isolation of single-domain antibody fragments that preferentially detect intact (146s) particles of foot-and-mouth disease virus for use in vaccine quality control

Frontiers in Immunology 8 , 960

Publisher’s version: https://doi.org/10.3389/fimmu.2017.00960

Groups

Viral Immunology

Dr Eva Perez

Pirbright grants licence for new foot-and-mouth disease vaccine

Persistently infected African buffalo not a likely cause of new FMD outbreaks say Pirbright scientists

Pirbright switches it up: creating foot-and-mouth disease hybrids for better vaccines

Pirbright study to improve the production and supply of foot-and-mouth disease vaccine

Designing foot-and-mouth disease synthetic vaccine design using computer simulations

Persistent infection of African buffalo (Syncerus caffer) with foot-and-mouth disease virus: limited viral evolution and no evidence of antibody neutralization escape

Within-host recombination in the foot-and-mouth disease virus genome

Detection of pathogen exposure in African buffalo using non-specific markers of inflammation

Chimeric O1K foot-and-mouth disease virus with SAT2 outer capsid as an FMD vaccine candidate

Universal detection of foot and mouth disease virus based on the conserved VP0 protein

Isolation of single-domain antibody fragments that preferentially detect intact (146s) particles of foot-and-mouth disease virus for use in vaccine quality control

Pages

Contact

Trim content

You are here

Groups

Dr Eva Perez

Pages

Contact

Trim content